Investing Profile

Carol Gallagher

OperatorAdvisor

Partner at New Enterprise Associates (NEA)

Your Intro Paths to Carol Gallagher

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Carol is a member of

Self Employed Network

133 CONNECTIONS

New Enterprise Associates (NEA) Network

94 CONNECTIONS

New Enterprise Associates (NEA) Network

94 CONNECTIONS

New Enterprise Associates (NEA) Network

94 CONNECTIONS

Pfizer Network

61 CONNECTIONS

Find Carol Gallagher on

Current Investing Position

Investments On Record

Current Fund Size

$6.2B

Carol Gallagher is on these Sector & Stage Rankings

Carol Gallagher's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Recludix Pharma	Series ANov 2021$60M	$60M
Co-investors: Matthew McAviney (New Enterprise Associates (NEA))
ChromaCode	Series CDec 2019$28M	$50M
Co-investors: Jenny Yip (Adjuvant Capital), Charles Petty (Global Health Investment Corporation), James Blair (Domain Associates, LLC), Justin Klein (Vensana Capital)
Millendo Therapeutics	Series UnknownAug 2018$30M Series BJan 2016$62M	$110M
Co-investors: Bill Harrington (Osage University Partners (OUP)), James N. Topper (Xelas Consulting LLC)
Metacrine	Series CJun 2018$65M Series BDec 2017$22M	$140M
Co-investors: Anup Arora (K2 HealthVentures)
Pionyr Immunotherapeutics	Series BDec 2017$62M	$79M
Co-investors: Jack Kenney (SV Health Investors), Leon Chen (The Column Group), Michael Powell (Omega Funds), Arjun Goyal (Vida Ventures, LLC)
Good2Go, Inc.	Seed RoundSep 2017$7M	$7M
Co-investors: Ruby Lee (Juni Learning)
Good2Go, Inc	SeedSep 2017$7M	$7M
Co-investors: Bob Pavey (Morgenthaler Ventures), Shailesh Rao (TPG Biotech), Corey Goodman (venBio Partners), Nancy Schoendorf (Mohr Davidow Ventures)
Cleave Therapeutics	Series BAug 2016$37M Series AApr 2013$10M	$100M
Co-investors: Kush Parmar (5am Ventures), Andrew Schwab (5am Ventures), Peter Thompson (OrbiMed), Marc Singer (Osage University Partners), Robert Garland (CrowdQuest), Alfred Scheidegger (Nextech Invest), Larry Lasky (The Column Group)

Carol Gallagher's Experience

Marketing Associate Eli Lilly and CompanyPresent

Marketing Manager AmgenPresent

National Account Manager AmgenPresent

Director, Global Marketing Planning Eli Lilly and CompanyPresent

Director, New Product Planning PfizerPresent

Senior Director, Oncology Marketing IDEC USAPresent

Director, Oncology Marketing and Rituxan Team Leader BiogenPresent

VP, Sales, Markeitng, and Product Planning Eli Lilly and CompanyPresent

SVP, Corp Development Eli Lilly and CompanyPresent

SVP, Corporate Development Anadys PharmaceuticalsPresent

Venture Advisor New Enterprise Associates (NEA)Present

Independent Board Director Self EmployedPresent

President and CEO Eli Lilly and CompanyPresent

Past President and CEO Calistoga PharmaceuticalsPresent

Partner New Enterprise Associates (NEA)Present

Venture Partner New Enterprise Associates (NEA)Present

Carol Gallagher's Education

University of Kentucky Pharm.D. Pharmacy

Investors who invest with Carol Gallagher

Scouts & Angels Affiliated With Carol Gallagher